Diane is the chief executive officer of a U.S.-based pharmaceutical firm. Over the years, she has been purchasing significant amounts of stock in the company
The rejection of the company's new drug, by the FDA, resulted in a huge drop in the company's stock value. Diane knew of the rejection before it was made public and sold her stock. Diane is guilty of ________.
A) false accounting
B) black marketeering
C) insider trading
D) influence peddling
C
Business
You might also like to view...
Name and describe the three different types of cost advantage a business can achieve to attain a competitive advantage. Be sure to explain how each type results in a competitive advantage
What will be an ideal response?
Business
Brands are built only by advertising
Indicate whether the statement is true or false
Business